Burning Rock Biotech (BNR) Total Debt (2019 - 2026)

Burning Rock Biotech (BNR) posted quarterly Total Debt of $275000.0 for Q1 2026, up 2.66% quarter-over-quarter from $267885.9 in Q4 2025.

Burning Rock Biotech (BNR) Total Debt (2019 - 2026) Analysis & Trends

Burning Rock Biotech's Total Debt history runs 6 years deep, the most recent figure standing at $275000.0 for Q1 2026.

In Q1 2026, Total Debt changed N/A year-over-year to $275000.0; the TTM figure through Mar 2026 stood at $275000.0 (changed N/A YoY), while the FY2025 annual figure was $267885.9, changed N/A from the prior year.
Total Debt for Q1 2026 stood at $275000.0, up from $267885.9 in the prior quarter.
The five-year high for Total Debt was $354000.0 in Q2 2022, with the low at $253000.0 in Q3 2025.
The 3-year median for Total Debt is $275000.0 (2026), against an average of $285777.2.
Peak annual rise in Total Debt reached 92.41% in 2022, while the deepest fall reached 92.41% in 2022.
Burning Rock Biotech's Total Debt stood at $354000.0 in 2022, then slipped by 24.33% to $267885.9 in 2025, then climbed by 2.66% to $275000.0 in 2026.
Business Quant data shows BNR's Total Debt at $275000.0 in Q1 2026, $267885.9 in Q4 2025, and $253000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Thermo Fisher Scientific	213.78 Bn	209.71 Bn	8.34 Bn	45.65 Bn
2	Danaher	139.83 Bn	135.48 Bn	3.61 Bn	26.56 Bn
3	Idexx Laboratories	45.98 Bn	45.78 Bn	779.09 Mn	818.87 Mn
4	Agilent Technologies	39.70 Bn	37.89 Bn	990.00 Mn	3.36 Bn
5	Iqvia Holdings	39.38 Bn	37.30 Bn	1.44 Bn	16.00 Bn
6	Natera	38.63 Bn	37.53 Bn	696.04 Mn	22.35 Mn
7	Illumina	29.92 Bn	28.75 Bn	770.00 Mn	1.49 Bn
8	Mettler Toledo International	28.55 Bn	28.50 Bn	650.22 Mn	2.11 Bn
9	Quest Diagnostics	26.17 Bn	25.54 Bn	1.03 Bn	5.65 Bn
10	Burning Rock Biotech	781.17 Mn	711.04 Mn	11.31 Mn	275,000.00

Download Data